FIELD: organic chemistry, biochemistry. SUBSTANCE: invention describes compounds of the formula (I) 
where substitutes have values given in description as separate stereoisomers or their mixtures and their pharmaceutically acceptable salts. Proposed compounds inhibit activity of matrix metalloproteases, for example, interstitial collagenases and can be used for treatment morbid states in mammals relieved by inhibition of such matrix metalloproteases, for example, arthritis or diseases associated with bone resorption, for example, osteoporosis. Invention describes also preparing pharmaceutical composition comprising compound of the formula (I) as active component and pharmaceutically acceptable addition. EFFECT: improved method of preparing, valuable medicinal properties. 23 cl, 13 sch, 73 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES, PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2132851C1 |
| MACROCYCLIC UREA AND SULPHAMIDE DERIVATIVES AS TAFIa INHIBITORS | 2009 |
|
RU2502736C2 |
| METHOD OF PRODUCING (4,2,0)BICYCLOOCTANE DERIVATIVES OF THEIR PHARMACEUTICALLY ACCEPTABLE NON-TOXIC SALTS OR PHARMACEUTICALLY ACCEPTABLE NON-TOXIC ESTERS | 0 |
|
SU1500153A3 |
| METHOD OF PRODUCING (4,2,0)-BICYCLOCTANE DERIVATIVES OF THEIR PHARMACEUTICALLY ACCEPTABLE NON-TOXIC SALTS | 0 |
|
SU1588275A3 |
| SUBSTITUTED CARBOXAMIDES AND PHARMACEUTICAL COMPOSITION ON SAID | 1994 |
|
RU2132327C1 |
| PHARMACEUTICALLY EFFECTIVE COMPOUNDS SELECTIVELY INHIBITING MYOSIN 2 ISOFORMS | 2019 |
|
RU2817643C2 |
| CARBOXAMIDES, METHOD OF PREPARING THEREOF, AND PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2163232C2 |
| FUNCTIONALISED DERIVATIVES OF MORPHOLINYLANTHRACYCLINE | 2015 |
|
RU2715902C2 |
| DERIVATIVES OF 10,11-METHANEDIBENZOSUBERANE, CHEMOSENSIBILIZING COMPOSITION, METHOD RESISTANCE TO ANTITUMOR DRUG OVERCOMING AND METHOD OF TREATMENT OF PATIENTS WITH TUMOR DISEASES | 1994 |
|
RU2167154C2 |
| PROCESS FOR PREPARING DERIVATIVES OF THIOETHYANIC ACID | 0 |
|
SU1052161A3 |
